Trulieve Reports Fourth Quarter Revenues Of $US79.7 Million

Trulieve Cannabis (CSE: TRUL) reported its fourth quarter and full fiscal year 2019 financial results this morning, posting revenues of US$79.7 million for the quarter, an increase of 13% on a quarter over quarter basis, while posting a net income of $45.5 million.

Notably, the company changed certin terminology on its income statement from “cost of goods sold” to “production expenses and cost of goods from third party suppliers,” which for the fourth quarter came to $28.1 million, resulting in what would typically be referred to as a gross margin of $51.5 million. Total revenues for the year came in at $252.8 million, on a gross margin of $163.0 million.

With respect to expenses, the company seems to operate at a much more respectable level than most of its competitors, recognizing administrative expenses of $14.0 million for the full fiscal year. Sales and marketing was significantly higher at $53.9 million, while depreciation and amortization came in at $8.3 million. Total expenses for the year came in at $76.4 million, resulting in a net income of $178.0 million for the year once fair value adjustments are taken into consideration.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

In terms of the balance sheet, most of the firms current assets are made up of inventories, which currently sits at $204.4 million, compared to cash of $91.8 million. Comparatively, last quarter those figure were $144.3 million and $31.0 million respectively. Biological assets was relatively unchanged comparatively, growing to $66.7 million from $62.4 million in the third quarter. Total current assets amounted to $369.9 million.

Total current liabilities also grew during the quarter, albeit at a much slower pace. Accounts payable grew to $24.3 million, while income tax payable grew to $12.2 million. Previously, those figures were reported as $16.9 million and $8.4 million in the third quarter respectively. The largest decrease in terms of payables was current portions of related party notes payable, which shrunk from $13.2 million to $0.9 million, due to the extension of an unsecured promissory note. Total current liabilities currently sits at $56.7 million, versus $49.0 million in the third quarter. This leaves Trulieve with a working capital of approximately $313.1 million.

Other notable items included in today’s release, include the announcement that the company understated the value of compensation warrants issued in 2018 by approximately $15.0 million, as well as a note that Kim Rivers husband, J.T. Burnette, whom is a minority shareholder, was the supplier for over $46.3 million in property plant and equipment purchases. Those purchase are said to have been reviewed by independent members of the company’s board of directors.

Trulieve Cannabis last traded at $13.85 on the CSE.


Information for this briefing was found via Sedar and Trulieve Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Trulieve Prices Public Offering At C$198.1 Million

Trulieve Cannabis (CSE: TRUL) this evening released the pricing of their previously announced public offering...

Wednesday, April 7, 2021, 08:26:04 PM

Planet 13 Acquires Florida License From Harvest Health

Planet 13 Holdings (CSE: PLTH) is officially headed to Florida. The firm this morning indicated...

Friday, October 1, 2021, 08:28:16 AM

Trulieve Sees Consensus Price Target Tumble After Cutting Guidance

Trulieve Cannabis (CSE: TRUL) reported its second quarter financial results on Wednesday. The company announced...

Thursday, August 11, 2022, 04:39:00 PM

Trulieve Sees Canaccord Maintain $35 Price Target Days Before Share Unlock

Trulieve Cannabis (CSE: TRUL) this morning saw Canaccord Genuity reaffirm its speculative buy rating on...

Wednesday, May 13, 2020, 11:20:52 AM

Trulieve’s Net Losses In Q3 2022 Widened By Five Times

The cannabis firm sees revenue down sequentially while inventories are on an upward trend. Trulieve...

Thursday, November 10, 2022, 03:14:00 PM